NEWS

Mesoblast shares plunge after FDA questions treatment

MELBOURNE: Shares in Stem-cell focused biotech Mesoblast dived more than 30 per cent ... read more

JobKeeper dividends fail ‘pub test’ claims Labor

CANBERRA: Labor says companies paying higher dividends while receiving millions of dollars in ... read more

JobKeeper lifts dividend prospects from raft of retailers

MELBOURNE: Retailers receiving millions of dollars in federal government wage subsidies from the ... read more

Atomo climbs 16pc after TGA test approval

MELBOURNE: The healthcare community and broader market initially misunderstood the role of Atomo ... read more